Maryamsadat Hashemi has been born in Iran 12 May 1987. She received bachelor education in Applied mathematics Science at University of Shahrerey, in 2010. In 2018 she received a master degree in Pharmacy at University of Turin, Italy. During her thesis she studied, L-type calcium channel gating defects induced by CACNA1D mutation associated with autistic spectrum disorder. She started her PhD course in Experimental Neuroscience at the University of Milano-Bicocca (Monza, Italy). Her PhD research project involves the investigation neurotoxicity of antineoplastic agents and possible role of MAP1B-LC1 protein complex in Cav3.2 channel trafficking.
- In vitro and in vivo study of antineoplastic agents’ neurotoxicity mechanisms
- Calcium channel role in neuropathic pain.
- Drug development for oncology